2009 results preview: big pharma grapples to varying degrees of success with generic erosion
This article was originally published in Scrip
Executive Summary
After an extraordinary year of financial emergency, businesses globally are entering 2010 with tentative hopes for improving conditions. The impending announcement of companies' fourth-quarter results will give an early indication of the trends, and the full-year results will paint the final picture that defines 2009.